
|Articles|June 20, 2017
- June 2017 Women's Health
- Volume 83
- Issue 6
Can You Read These Rxs? (June 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
over 9 years ago
Case Studies (June 2017)over 9 years ago
Pet Peeves (June 2017)over 9 years ago
Generic Product News (June 2017)over 9 years ago
Naloxone Nasal Spray More Generics on the Horizon?over 9 years ago
Medication Therapy Management and Health Care Reformover 9 years ago
Mental Illness Linked to Heightened Cardiovascular Disease Riskover 9 years ago
Poor Diet Linked to Premenopausal Breast Cancer RiskAdvertisement
Related to this article

Pharmacists can use medication therapy management to screen for diabetes, educate patients about medication adherence and lifestyle modifications, and support early action.

Higher doses of injectable semaglutide have been shown to cause greater weight loss than standard doses with a similar safety profile.

In every practice setting, pharmacists can meet vaccine hesitancy with evidence, effective communication, and vetted resources that move patients toward “yes.”

Retail pharmacists use a quick checklist to spot risky antithrombotic duplicates, dosing mistakes, OTC interactions, and adherence gaps—helping prevent stroke and bleeding.

Health-system pharmacists confirm therapy matches stroke mechanism, screen for bleeding risk and drug interactions, and help patients transition to outpatient care.

Peer Reviewed
Identifying and screening Medicare Part D patients who are ordered brand-name cardiovascular medications for PACE/PACENET eligibility before discharge can reduce patients’ out-of-pocket costs for these medications.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Two-Drug HIV Regimens, Archived M184V Resistance, and Long-Acting Preference
2
Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options
3
SNO 2026 Roundup: What Longer Follow-Up Means for Targeted Glioma Care
4
Overton FDA Nomination Withdrawn: What It Means for Pharmacists
5


